Dave: let me chime in here man. A large payment to get a stake in Lympro would be better than a sale right now. Honestly, AMBS could get a very large sum of money for a stake in the product or diagnostic spin off in total followed by collection of revenue over time. Best of both worlds really while value is built even more.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links